Menzo Havenga
Algemeen Directeur bij Batavia Biosciences BV
Profiel
Menzo Havenga is the founder of Batavia Biosciences BV, which is founded in 2010, where he holds the title of President & Chief Executive Officer.
He was also a Research Director at Introgene BV from 1994 to 2001.
Dr. Havenga was the Managing Director at Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk.
He was also the Vice President-Research & Development at Crucell NV from 2001 to 2007.
Dr. Havenga holds a doctorate degree from the University of Leiden.
Actieve functies van Menzo Havenga
| Bedrijven | Functie | Begin |
|---|---|---|
Batavia Biosciences BV
 Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands. | Algemeen Directeur | 20-10-2010 |
Eerdere bekende functies van Menzo Havenga
| Bedrijven | Functie | Einde |
|---|---|---|
Crucell NV
 Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Hoofd Techniek/Wetenschap/O&O | 01-01-2007 |
| Introgene BV | Hoofd Techniek/Wetenschap/O&O | 01-01-2001 |
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
 Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Corporate Officer/Principal | - |
Opleiding van Menzo Havenga
| University of Leiden | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Batavia Biosciences BV
Batavia Biosciences BV Pharmaceuticals: MajorHealth Technology Batavia Biosciences BV provides biopharmaceutical process development services. It offers biopharmaceutical materials research and pre-clinical study services for biopharmaceutical clients. The firm services cover candidate selection, production of research materials, upstream and downstream process development, assay development, product characterization and clinical manufacturing and release. The company was founded in 2010 and is headquartered in Leiden, the Netherlands. | Health Technology |
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk
Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk Miscellaneous Commercial ServicesCommercial Services Nederlandse Organisatie voor Toegepast-Natuurwetenschappelijk provides scientific services. It includes research and consultancy for government, businesses and organizations. The company was founded in 1932 and is headquartered in Delft, Netherlands. | Commercial Services |
Crucell NV
Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
| Introgene BV | Health Technology |
